You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

autologous dendritic cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

Completed
  • Stage III Malignant Melanoma of Skin AJCC V6
  • Stage IV Malignant Melanoma of Skin
  • TAPCells vaccine
  • Santiago, RM, Chile
    Faculty of Medicine, University of Chile
Nov 21, 2023

Castration Resistant Prostate Cancer, CRPC Trial in Seoul (Cellgram-DC-PC)

Terminated
  • Castration Resistant Prostate Cancer, CRPC
  • Cellgram-DC-PC
  • Seoul, Korea, Republic of
    Asan medical center
Dec 29, 2022

Ovarian Cancer Trial in Seoul (Cellgram-DC)

Terminated
  • Ovarian Cancer
  • Cellgram-DC
  • Seoul, Korea, Republic of
    Asan medical center
Dec 29, 2022

Uveal Melanoma Trial in Germany (Autologous Dendritic Cells loaded with autologous Tumor RNA)

Active, not recruiting
  • Uveal Melanoma
  • Autologous Dendritic Cells loaded with autologous Tumor RNA
  • Erlangen, Bayern, Germany
  • +7 more
Nov 29, 2022

Nasopharyngeal Cancer Trial in Jakarta (Auto-Dendritic Adjuvant Therapy, Allo-Dendritic-Secretome Adjuvant Therapy)

Not yet recruiting
  • Nasopharyngeal Cancer
  • Auto-Dendritic Adjuvant Therapy
  • Allo-Dendritic-Secretome Adjuvant Therapy
  • Jakarta, Indonesia
    PT Prodia StemCell Indonesia
Mar 1, 2022

Myocardial Infarction Trial in Seoul (Autologous peripheral blood-derived tolerogenic dendritic cells)

Recruiting
  • Myocardial Infarction
  • Autologous peripheral blood-derived tolerogenic dendritic cells
  • Seoul, Korea, Republic of
    Eun Ho Choo
Sep 21, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Active, not recruiting
  • Stage III Cutaneous Melanoma AJCC v7
  • +4 more
  • Cryosurgery
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 3, 2023

Melanoma Trial in New York (Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs))

Completed
  • Melanoma
  • Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 12, 2023

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Los Angeles

Completed
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • AdGMCAIX-transduced autologous dendritic cells
  • +2 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Jul 28, 2021

Stage III Hepatocellular Carcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Hepatocellular

Recruiting
  • Stage III Hepatocellular Carcinoma AJCC v8
  • +11 more
  • External Beam Radiation Therapy
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 1, 2022

Stage III Ovarian Carcinoma, Stage IV Ovarian Carcinoma, Fallopian Tube Carcinoma Trial in United States (AVOVA-1, MC)

Active, not recruiting
  • Stage III Ovarian Carcinoma
  • +3 more
  • AVOVA-1
  • MC
  • Burbank, California
  • +5 more
Apr 21, 2022

Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous

Active, not recruiting
  • Malignant Neoplasms of Brain
  • tetanus toxoid
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Ovarian Carcinoma
  • XP-DC vaccinations
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Mar 6, 2023

Alzheimer Trial (ALZN002 (autologous DCs pulsed with E22W mutant peptide)., Placebo)

Not yet recruiting
  • Alzheimer Disease
  • ALZN002 (autologous DCs pulsed with E22W mutant peptide).
  • Placebo
  • (no location specified)
Apr 17, 2023

Newly Diagnosed Glioblastoma Trial in United States (AV-GBM-1)

Active, not recruiting
  • Newly Diagnosed Glioblastoma
  • AV-GBM-1
  • La Jolla, California
  • +7 more
Dec 14, 2021

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 13, 2022

Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

Not yet recruiting
  • Refractory Leukemia
  • +4 more
  • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
  • Dendritic Cell Vaccine
  • Miami, Florida
    University of Miami
Jan 23, 2023

GBM Trial in Taichung, Taoyuan (autologous dendritic cells)

Recruiting
  • GBM
  • autologous dendritic cells
  • Taichung, Non-US, Taiwan
  • +2 more
Mar 21, 2022

COVID-19 Trial (AV-COVID-19)

Not yet recruiting
  • COVID-19
  • AV-COVID-19
  • (no location specified)
Dec 14, 2021

Multiple Myeloma Trial in New York (CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs), Standard of care)

Completed
  • Multiple Myeloma
  • CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs)
  • Standard of care
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 22, 2022

Diabetes Trial (Autologous tolerogenic dendritic cells, Standard treatment according to the clinical protocols)

Not yet recruiting
  • Diabetes Mellitus
  • Autologous tolerogenic dendritic cells
  • Standard treatment according to the clinical protocols
  • (no location specified)
Jan 12, 2022

Glioblastoma, Vaccination Trial in Meldola (Autologous Dendritic Cells (DC) vaccine, Temozolomide)

Not yet recruiting
  • Glioblastoma
  • Vaccination
  • Meldola, FC, Italy
    Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumor
Feb 25, 2021

Glioblastoma Multiforme of Brain Trial in Beijing (Autologous dendritic cells pulsed with multiple neoantigen peptides.,

Recruiting
  • Glioblastoma Multiforme of Brain
  • Autologous dendritic cells pulsed with multiple neoantigen peptides.
  • Temozolomide adjuvant chemotherapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Jan 13, 2022

Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard

Completed
  • Glioblastoma
  • +4 more
  • Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
  • Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 18, 2021

Melanoma, Uveal Metastatic Trial in Erlangen (Vaccination with IKKb matured Dendritic Cells)

Active, not recruiting
  • Melanoma, Uveal Metastatic
  • Vaccination with IKKb matured Dendritic Cells
  • Erlangen, Bavaria, Germany
    University Hospital Erlangen Dept. of Dermatology
Mar 16, 2022